During the past decade, Kirovograd Regional Oncological Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kirovograd Regional Oncological Center" are "Chemotherapy-induced Neutropenia" (3 trials). Many other conditions were trialed in "Kirovograd Regional Oncological Center" in a lesser frequency.

Most popular intervention types in "Kirovograd Regional Oncological Center" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pegfilgrastim" (3 trials), "Plinabulin" (3 trials), "Docetaxel, doxorubicin, and cyclophosphamide (TAC)" (2 trials) and "D5W Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kirovograd Regional Oncological Center" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Kirovograd Regional Oncological Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kirovograd Regional Oncological Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kirovograd Regional Oncological Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".